Mandatory Switch Policies Drive Biosimilar Uptake, Reduce CostsJune 2nd 2023
Abstracts presented at EULAR 2023 highlighted the impact that a mandatory switching policy had on biosimilar uptake in British Columbia, Canada, and the lack of uptake when no such policy was in place in the United States.
US Government Spent Far More on Costly HIV PrEP Development Than Previously ThoughtJune 2nd 2023
According to new estimates, the US government spent between $143 million and $314 million in 2022 inflation-adjusted dollars funding the development of tenofovir disoproxil fumarate-emtricitabine. The previous estimate was around $50 million.
What We’re Reading: Biden Eyes Cohen for CDC; Bias in PFTs; US Birthrate Stays Flat
President Joe Biden has reportedly picked former North Carolina health chief Mandy Cohen, MD, MPH, as next head of the CDC; Black men were probably underdiagnosed with lung problems because of software bias; the US birthrate remains flat.
Stakeholder Analysis: Medicare Diabetes Prevention Program Awareness and ImplementationJune 2nd 2023
This article describes facilitators of and barriers to uptake of the underutilized Medicare Diabetes Prevention Program from the perspectives of health care providers and program suppliers in western Pennsylvania.
Medicare Patients With HSNCC Fare Better Than Younger CounterpartsJune 2nd 2023
Deemed the “Medicare” effect, patients aged 65 years who have Medicare coverage had an increased incidence of head and neck squamous cell carcinoma (HNSCC) but were less likely to receive a late-stage diagnosis and had lower mortality rates.
Atopic Eczema in Infants Linked to Antibiotic Exposure in First YearJune 1st 2023
There are recent reports of a potential connection between atopic dermatitis in infants and young children and early exposure to antibiotics and laxatives; however, the totality of the evidence on this link remains lacking.
EHA 2023 to Augment Trial Results With the Voice of the PatientJune 1st 2023
The 2023 European Hematology Association (EHA) Congress, convening virtually and in Frankfurt, Germany, from June 8-11, 2023, will feature cutting-edge findings in oncology and hematology, with a special focus on incorporating patient-reported outcomes and real-world data.